Multifocal VEP in children: its maturation and clinical application

C Balachandran1, A I Klistorner, F Billson

  • 1Save Sight Institute, Department of Ophthalmology, University of Sydney, Macquarie Street, PO Box 1614, Sydney 2001, Australia. Chandra@eye.usyd.edu.au

Insights

Multifocal visual evoked potentials (VEP) mature with age in children, with amplitude increasing significantly between 11-13 years and latency stabilizing by 13. This objective test aids in diagnosing visual pathway diseases in children.

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Pediatrics

Background:

  • Assessing visual pathway maturation in children is crucial for diagnosing optic nerve diseases.
  • Multifocal visual evoked potentials (mfVEP) offer an objective method to evaluate visual function.

Observation:

  • mfVEP amplitude shows a sigmoid relationship with age, with significant development between 11-13 years.
  • Latency decreases with age, stabilizing around 13 years.
  • Scaled mfVEP amplitude demonstrates reduced variability and age-related changes across tested eccentricities.

Findings:

  • The study established normative mfVEP maturation data in 70 healthy children aged 5-16 years.
  • mfVEP successfully identified visual field defects in children with optic nerve glioma and congenital glaucoma.
  • Age-related changes in mfVEP amplitude and latency provide a developmental timeline for the visual pathway.

Implications:

  • mfVEP perimetry is a valuable, objective tool for diagnosing visual field deficits in pediatric patients.
  • This technique can document visual pathway abnormalities in children as young as 5 years old.
  • mfVEP can aid in early diagnosis and management of optic pathway diseases before subjective testing is feasible.
Abstract